Needham & Company raised its price target on Zimmer Biomet (NYSE: ZBH) to $155.00 (from $144.00) while maintaining a Strong ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Zimmer Biomet (ZBH) PT Raised to $138 at Baird on 4Q Report; 'Revenues Shows Signs of Stabilization'January 31, 2018 8:18 AM Zimmer Biomet (ZBH) PT Raised to $146 at Leerink PartnersJanuary 31, 2018 7:50 AM Zimmer Biomet Holdings (ZBH) Reports In-Line Q4 EPS; Guides Q1 Modestly Below the StreetJanuary 30, 2018 7:02 AM Zimmer Biomet Announces Fourth Quarter and Full-Year 2017 ResultsJanuary 30, 2018 7:00 AM